409 filings
Page 12 of 21
8-K
wrhuru0yf21 4s
10 Sep 13
Regulation FD Disclosure
12:00am
8-K
ombd32vu6hvgh4as2
9 Sep 13
Other Events
12:00am
8-K
d73wut
6 Sep 13
Other Events
12:00am
8-K
rt4xy 7up7
5 Sep 13
Regulation FD Disclosure
12:00am
8-K
15e66pu
4 Sep 13
Regulation FD Disclosure
12:00am
8-K
mrt1lng5z0czxkyk7c
30 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
xwjwt
25 Jul 13
Two U.S. Product Approvals in the Second Quarter 2013
12:00am
8-K
ld7d 13i2b1p8e7o136
10 Jul 13
Breo™ Ellipta™ Approved for Copd Treatment In Canada
12:00am
8-K
il91u4rl y22i1fdj
24 Jun 13
Other Events
12:00am
8-K
hezxf zlx
21 Jun 13
Termination of a Material Definitive Agreement
12:00am
8-K
xdvnue 7lv
21 Jun 13
Other Events
12:00am
8-K
mbhuyu0r3fwx
17 Jun 13
Theravance remains focused on strategy to separate late-stage partnered respiratory assets from biopharmaceutical operations
12:00am
8-K
vgrso irg
4 Jun 13
Other Events
12:00am
8-K
f1jx6ta6c3m1
3 Jun 13
Regulation FD Disclosure
12:00am
8-K
mot9ik9cwlmkf
21 May 13
Other Events
12:00am
8-K
4t9f9t0d6 8y
20 May 13
Other Events
12:00am
8-K
zh8fttj
20 May 13
Other Events
12:00am
8-K
cug92
16 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
7x4kreoi
13 May 13
Regulation FD Disclosure
12:00am
8-K
zk5v 9lb4w8x0pdee
10 May 13
Regulation FD Disclosure
12:00am